Indogulf Cropsciences Q1FY27 net profit down 38% YoY; EBITDA margin rises to 6%
Indogulf Cropsciences reported Q1FY27 net profit of ₹24 million, down 38% YoY, while revenue rose 12% QoQ to ₹1,685 million. EBITDA margin improved to 6%. The company highlighted a diversified product mix with crop protection contributing 87% of revenue and expanded global reach with exports accounting for 13% of sales.
*this image is generated using AI for illustrative purposes only.
Indogulf Cropsciences Limited reported a consolidated net profit of ₹24 million for the quarter ended June 30, 2026 (Q1FY27), marking a 38% decline from the ₹39 million profit recorded in Q1FY26. While profitability contracted on a year-on-year basis, the company delivered a sequential recovery, with revenue rising 12% quarter-on-quarter to ₹1,685 million from ₹1,508 million in Q4FY26. The EBITDA margin improved to 6% in Q1FY27, up from 5.24% in the corresponding quarter of the previous fiscal year, reflecting management's focus on operational efficiency and product mix optimization.
The Board of Directors approved the unaudited standalone and consolidated financial results during a meeting held on August 12, 2026, at the company's registered office in New Delhi. The results were reviewed by the Audit Committee and subjected to a limited review by the statutory auditors, Devesh Parekh & Co., in compliance with Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The press release was issued on August 13, 2026, followed by the release of the investor presentation on August 14, 2026.
Consolidated revenue from operations stood at ₹1,685 million for Q1FY27, down 11% year-on-year from ₹1,894 million. Standalone revenue figures were not explicitly detailed in the new release but previously contracted by 12.3% to ₹1,623.96 million in the prior reporting cycle. Other income decreased marginally to ₹8.85 million on a consolidated basis in the earlier report. The sequential growth in revenue highlights an improvement in business momentum following a weaker preceding quarter.
Financial Performance Breakdown
The following table summarises the key financial metrics across consolidated bases for Q1FY27, comparing year-on-year and quarter-on-quarter performance:
| Metric | Consolidated Q1FY27 | Consolidated Q1FY26 | Y-o-Y Change | Consolidated Q4FY26 | Q-o-Q Change |
|---|---|---|---|---|---|
| Revenue from Operations (₹ Million) | 1,685 | 1,894 | -11% | 1,508 | +12% |
| EBITDA (₹ Million) | 96 | 99 | -4% | 204 | -53% |
| EBITDA Margin (%) | 6% | 5.24% | +76 bps | 14% | -833 bps |
| Profit After Tax (₹ Million) | 24 | 39 | -38% | 116 | -79% |
| PAT Margin (%) | 1% | 2% | -57 bps | 8% | -657 bps |
| EPS Basic (₹) | 0.4 | 0.8 | -53% | 2.3 | -83% |
The company's total consolidated expenses amounted to ₹1,662.75 million in the prior reporting cycle, with the cost of raw material and components consumed being the largest component at ₹1,465.84 million. Employee benefits expense rose to ₹137.13 million from ₹126.71 million in the year-ago period. Finance costs increased to ₹45.10 million from ₹37.85 million. Gross profit grew 12% year-on-year to ₹466 million, with gross margin improving to 28%.
Business Operations and Expansion
Indogulf Cropsciences continues to strengthen its integrated agri-solutions portfolio across crop protection, plant nutrients, and biologicals. The company engaged over 100,000 farmers through an on-ground network of more than 100 Institutional Distributors (IDOs), supported by field demonstrations and advisory-led initiatives. Its distribution platform operates through over 7,500 distributors, 192 active institutional partners, 30 stock depots, and 333 sales and marketing personnel across India.
Global expansion remains a key focus, with a presence in over 36 countries supported by 140 active overseas business partners and 189 registrations. Manufacturing capacity utilization increased to 70% in Q1FY27 from 52% in FY26, while the expansion of the Barwasni facility continues. The company holds 300+ products, 1,000+ registrations, and six patents, with a strategic emphasis on next-generation biological and sustainable solutions.
Product Mix and Revenue Channels
The investor presentation disclosed that crop protection contributed 87% of revenue in Q1FY27, while biologicals and plant nutrients each accounted for 3%, with others making up the remaining 7%. Revenue channels were diversified, with business-to-consumer (B2C) sales comprising 47%, business-to-business (B2B) sales at 31%, exports at 13%, and other channels at 9%. Export momentum was supported by geographic diversification into new markets including Venezuela, Taiwan, and Sri Lanka.
What the Numbers Show
A key observation from the Q1FY27 results is the divergence between the sharp year-on-year decline in net profit and the improvement in operating margins. While net profit fell 38% to ₹24 million, the EBITDA margin expanded to 6% from 5.24% in the prior year, and gross margin improved to 28%. This suggests that while top-line pressures persisted (revenue down 11% YoY), operational efficiencies and product mix shifts helped protect operating leverage. However, the significant drop in PAT margin to 1% from 2% indicates that non-operating factors or higher finance costs may have impacted the bottom line disproportionately to operating performance. The sequential revenue recovery of 12% provides a positive signal for business momentum entering the new fiscal year.
Historical Stock Returns for Indogulf Cropsciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.79% | +1.23% | -5.94% | +11.08% | -29.99% | 0.0% |
How will the ongoing expansion of the Barwasni facility impact Indogulf's capacity utilization rates and cost structure in Q2FY27?
What specific strategies is management implementing to mitigate the rising finance costs that contributed to the disproportionate drop in PAT margins?
Can the sequential revenue growth of 12% sustain momentum into Q2FY27, or are seasonal factors likely to cause another contraction?
16
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
